Abstract:Objective: In thyroid-associated ophthalmopathy (TAO), long disease duration is negatively correlated with the response to immunosuppression treatment. The current treatment decision-making process does not involve magnetic resonance imaging (MRI); thus, we investigated the predictive value of MRI parameters for the immunosuppressive response in active moderate to severe TAO patients with different disease durations. Methods: We retrospectively analyzed the baseline MRI parameters of active TAO patients treated with guideline-recommended weekly glucocorticoid therapy in our center. Data were stratified by the quartile of disease duration. The signal intensity ratio (SIR) of T2-weighted images was used to describe the activity of extraocular muscles (EOMs). Results: Compared to the lowest quartile of disease duration, SIR values of EOMs were significantly lower in quartile 3 (Q3) and quartile 4 (Q4). Meanwhile, the clinical activity score (CAS) curve did not change in parallel and was not correlated with the SIR curve. In the highest quartile of disease duration, nonresponders had significantly lower SIR values of the most inflamed muscle (P = .03) and the medial rectus (P = .004) than did the responders, while no such significance was observed in patients within the lower 3 quartiles. A multivariable predictive model (including CAS, TAO duration, and SIR value) was established in each quartile. The fit of the model was better than CAS with regard to prognostic prediction and showed a high positive predictive value (Model 1: 86.67%; Model 2: 92.86%) and negative predictive value (Model 1: 88.89%; Model 2: 90%) in the top quartile. Conclusion: The anterior manifestation assessed by CAS is not always consistent with retro-orbital activity in long-term TAO patients. CAS is sufficient to reflect disease activity in short-term TAO patients. The supplementation of CAS with orbital MRI would be valuable in selecting appropriate active patients with a long disease duration.

Predictive Model for the Progression of Inactive Thyroid Eye Disease: a Retrospective Study

Predictive markers for anti-inflammatory treatment response in thyroid eye disease

Peripheral CD3+CD4+ T Cells As Indicators of Disease Activity in Thyroid Eye Disease: Age-Dependent Significance

A data-driven approach for the discovery of biomarkers associated with thyroid eye disease

Prediction models of intravenous glucocorticoids therapy response in thyroid eye disease

Epidemiology of Thyroid-stimulating immunoglobulin in Recent Onset Symptomatic Thyroid Eye Disease

Clinical profile of thyroid eye disease and factors predictive of disease severity

CT-based artificial intelligence prediction model for ocular motility score of thyroid eye disease

A Chinese Survey of Clinical Practice on the Management of Thyroid Eye Disease

Future Projections in Thyroid Eye Disease

Novel insights into the pathogenesis of thyroid eye disease through ferroptosis-related gene signature and immune infiltration analysis

Thyroid eye disease: From pathogenesis to targeted therapies

One Incremental Stride for Doxycycline, One Substantial Advancement for Thyroid Eye Disease

Clinical relevance of thyroid-stimulating immunoglobulin as a biomarker of the activity of thyroid eye disease

The Changes of Retinal Nerve Fibre Layer and Ganglion Cell Layer with Different Severity of Thyroid Eye Disease

Predictive factors for treatment response in active thyroid eye disease

“Effectiveness of Different Treatment Modalities in Initial and Chronic Phases of Thyroid Eye Disease: A Systematic Review with Meta-analysis”

Neuroimaging in thyroid eye disease: A systematic review

ROLE OF MAGNETIC RESONANCE IMAGING IN THE ASSESSMENT OF ACTIVE THYROID-ASSOCIATED OPHTHALMOPATHY PATIENTS WITH LONG DISEASE DURATION.

Understanding Pathogenesis Intersects With Effective Treatment for Thyroid Eye Disease

The Correlation of the Neutrophil–lymphocyte Ratio to Clinical and Imaging Parameters in Patients with Thyroid Eye Disease